Ind-Swift Laboratories Ltd (INDSWFTLAB) — Announcement | 28 September 2026 (2 announcements)

28 September 2026 · BSE Neutral

By StockFin Research Team•AI-Assisted Analysis•Source: BSE/NSE Filings

1Announcement Neutral📄 PDF

📢 Key Event

Trading window closed for insiders until post-results period

💡 Investor Takeaway

Shareholders must avoid trading during the restricted period to comply with insider trading rules.

Ind-Swift Laboratories Ltd announced the closure of its trading window effective 1 October 2026, prohibiting insiders from trading shares until 48 hours after the release of un-audited financial results for the quarter and half-year ended 30 September 2026, as mandated by NSE and BSE regulations.

2Announcement Neutral📄 PDF

📢 Key Event

SEBI mandates PAN, KYC, and nomination updates for physical security holders

💡 Investor Takeaway

Shareholders must submit updated details to continue receiving payments and avoid service restrictions.

Ind-Swift Laboratories informed physical security holders that SEBI mandates updating PAN, KYC, and nomination details by April 1, 2024, or they cannot receive dividends or lodge grievances, requiring submission of specific forms to Alankit Limited via email, post, or in-person verification.

📊 Stock Analysis — INDSWFTLAB ✨ Ask AI About This

About Ind-Swift Laboratories Ltd (INDSWFTLAB)

Healthcare · Pharmaceuticals · Listed on BSE

Market Cap: ₹3,597.16 CrP/E: 60.6ROE: 4.1%ROCE: 5.2%

View full INDSWFTLAB stock details →

📡 Get AI alerts when INDSWFTLAB files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track INDSWFTLAB — Free

💡 Ask AI about this filing

"When will the un-audited financial results be declared?""What is the exact reopening date for trading after results?""How does this closure affect insider shareholding disclosures?"

Ask AI Free →

📊 More INDSWFTLAB filings

🔴 Announcement — 23 September 2026Ind-Swift Laboratories announced its schedule for an upcoming analyst and institutional investor mee...
regulation 29 — 21 September 2026Ind-Swift Laboratories disclosed that Essix Biosciences acquired 7 million fully convertible warrant...
🔴 Corporate Action — 17 September 2026Ind-Swift Laboratories announced the allotment of 7 million fully convertible warrants to Essix Bios...
🟡 Board Meeting — 5 September 2026Ind-Swift Laboratories announced its 31st Annual General Meeting scheduled for September 30, 2026, v...
🔴 Annual Report — 5 September 2026Ind-Swift Laboratories Ltd submitted its FY2025-26 annual report on 2026-09-05, confirming a pure-pl...

See all INDSWFTLAB filings →

🔥 Also filed on 28 September 2026

JSLJindal Stainless LtdCorporate Action GODREJPROPGodrej Properties LtdAnnouncement MANINFRAMan Infraconstruction LtdAnnouncement KPILKalpataru Projects International LtdAnnouncement SUNPHARMASun Pharmaceutical Industries LtdAnnouncement JUBLPHARMAJubilant Pharmova LtdCorporate Action

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when INDSWFTLAB files new disclosures

Track INDSWFTLAB filings, board meetings, and corporate actions. Free email alerts at 5 PM.